Six cases of a rare blood clotting disorder have led U.S. health officials to pause the use of Johnson & Johnson's Covid-19 vaccine. Though it's not known if the vaccine is behind the blood clotting, WSJ's Jonathan D. Rockoff says the pause could impact efforts to vaccinate the country.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Fler avsnitt av The Journal.
Visa alla avsnitt av The Journal.The Journal. med The Wall Street Journal & Spotify Studios finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
